Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
532.02
+9.45 (1.81%)
Jan 3, 2025, 4:00 PM EST - Market closed
Thermo Fisher Employees
Thermo Fisher Scientific had 122,000 employees as of December 31, 2023. The number of employees decreased by 8,000 or -6.15% compared to the previous year.
Employees
122,000
Change (1Y)
-8,000
Growth (1Y)
-6.15%
Revenue / Employee
$347,295
Profits / Employee
$50,287
Market Cap
203.50B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 122,000 | -8,000 | -6.15% |
Dec 31, 2022 | 130,000 | 0 | - |
Dec 31, 2021 | 130,000 | 50,000 | 62.50% |
Dec 31, 2020 | 80,000 | 5,000 | 6.67% |
Dec 31, 2019 | 75,000 | 5,000 | 7.14% |
Dec 31, 2018 | 70,000 | 0 | - |
Dec 31, 2017 | 70,000 | 15,000 | 27.27% |
Dec 31, 2016 | 55,000 | 3,000 | 5.77% |
Dec 31, 2015 | 52,000 | 1,000 | 1.96% |
Dec 31, 2014 | 51,000 | 1,000 | 2.00% |
Dec 31, 2013 | 50,000 | 11,100 | 28.53% |
Dec 31, 2012 | 38,900 | -400 | -1.02% |
Dec 31, 2011 | 39,300 | 2,100 | 5.65% |
Dec 31, 2010 | 37,200 | 1,800 | 5.08% |
Dec 31, 2009 | 35,400 | 900 | 2.61% |
Dec 31, 2008 | 34,500 | 1,500 | 4.55% |
Dec 31, 2007 | 33,000 | 2,500 | 8.20% |
Dec 31, 2006 | 30,500 | 19,000 | 165.22% |
Dec 31, 2005 | 11,500 | 1,600 | 16.16% |
Dec 31, 2004 | 9,900 | -900 | -8.33% |
Dec 31, 2003 | 10,800 | -100 | -0.92% |
Dec 28, 2002 | 10,900 | -1,100 | -9.17% |
Dec 29, 2001 | 12,000 | -1,000 | -7.69% |
Dec 30, 2000 | 13,000 | -12,400 | -48.82% |
Jan 1, 2000 | 25,400 | 1,800 | 7.63% |
Jan 2, 1999 | 23,600 | 1,200 | 5.36% |
Jan 3, 1998 | 22,400 | 4,640 | 26.13% |
Dec 28, 1996 | 17,760 | 3,360 | 23.33% |
Dec 30, 1995 | 14,400 | 4,166 | 40.71% |
Dec 31, 1994 | 10,234 | 1,434 | 16.30% |
Jan 1, 1994 | 8,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
TMO News
- 1 day ago - Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 - Business Wire
- 2 days ago - Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025 - Business Wire
- 17 days ago - Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific - Business Wire
- 22 days ago - Thermo Fisher: The Cycle Has Already Turned Around - Seeking Alpha
- 25 days ago - Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic - Seeking Alpha
- 4 weeks ago - Thermo Fisher: M&A And Innovation To Drive Sales Growth - Seeking Alpha
- 4 weeks ago - Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production - Business Wire
- 4 weeks ago - Thermo Fisher Scientific Completes $1B Share Repurchase - Business Wire